help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 30, 2003
Molecular Endocrinology, doi:10.1210/me.2003-0300
Molecular Endocrinology Vol. 0, No. 2003 200303001-
doi:10.1210/me.2003-0300
Copyright © 2003 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
18/1/117    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheviet, S.
Right arrow Articles by Regazzi, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheviet, S.
Right arrow Articles by Regazzi, R.

Submitted on July 31, 2003
Accepted on October 21, 2003

The Rab-binding protein Noc2 is associated with insulin-containing secretory granules and is essential for pancreatic {beta}-cell exocytosis

Séverine Cheviet1, Thierry Coppola1, Lee P. Haynes1, Robert D. Burgoyne1, and Romano Regazzi1*

1 Institut de Biologie Cellulaire et de Morphologie, University of Lausanne, Switzerland. The Physiological Laboratory, University of Liverpool, United Kingdom

* To whom correspondence should be addressed. E-mail: Romano.Regazzi{at}ibcm.unil.ch.

The small GTPases Rab3 and Rab27 are associated with secretory granules of pancreatic {beta}-cells and regulate insulin exocytosis. In this study, we investigated the role of Noc2, a potential partner of these two GTPases, in insulin secretion. In the {beta}-cell line INS-1E wild type Noc2, Noc265E and Noc258A, a mutant capable of interacting with Rab27 but not Rab3, colocalised with insulin-containing vesicles. In contrast, two mutants (Noc2138S,141S and Noc2154A,155A,156A) that bind neither Rab3 nor Rab27 did not associate with secretory granules and were uniformly distributed throughout the cell cytoplasm. Overexpression of wild type Noc2, Noc265E or Noc258A inhibited hormone secretion elicited by insulin secretagogues. In contrast, overexpression of the mutants not targeted to secretory granules was without effect. Silencing of the Noc2 gene by RNA interference led to a strong impairment in the capacity of INS-1E cells to respond to insulin secretagogues, indicating that appropriate levels of Noc2 are essential for pancreatic {beta}-cell exocytosis. The defect was already detectable in the early secretory phase (0-10 min) but was particularly evident during the sustained release phase (10-45 min). Protein-protein binding studies revealed that Noc2 is a potential partner of Munc13, a component of the machinery that controls vesicle priming and insulin exocytosis. These data suggest that Noc2 is involved in the recruitment of secretory granules at the plasma membrane possibly via the interaction with Munc13.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society